Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine in adults aged 60 years and older
2019-000655-14Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of quadrivalent influenza vaccine in influenza (2 arms), sponsored by Sanofi. Primary endpoint: Geometric mean titers of influenza vaccine antibodies post-vaccination. Started May 2019; status: completed.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2019-000655-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000655-14.